Annual CAPEX:
$519.50K+$234.90K(+82.54%)Summary
- As of today, MLTX annual capital expenditures is $519.50 thousand, with the most recent change of +$234.90 thousand (+82.54%) on December 31, 2024.
- During the last 3 years, MLTX annual CAPEX has risen by +$468.80 thousand (+924.65%).
- MLTX annual CAPEX is now at all-time high.
Performance
MLTX CAPEX Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Quarterly CAPEX:
$0.00-$35.00K(-100.00%)Summary
- As of today, MLTX quarterly capital expenditures is $0.00, with the most recent change of -$35.00 thousand (-100.00%) on June 30, 2025.
- Over the past year, MLTX quarterly CAPEX has stayed the same.
- MLTX quarterly CAPEX is now -100.00% below its all-time high of $284.60 thousand, reached on December 31, 2023.
Performance
MLTX Quarterly CAPEX Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM CAPEX:
$342.80K$0.00(0.00%)Summary
- As of today, MLTX TTM capital expenditures is $342.80 thousand, unchanged on June 30, 2025.
- Over the past year, MLTX TTM CAPEX has dropped by -$153.60 thousand (-30.94%).
- MLTX TTM CAPEX is now -45.47% below its all-time high of $628.60 thousand, reached on September 30, 2024.
Performance
MLTX TTM CAPEX Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
MLTX CAPEX Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1Y1 Year | +82.5% | 0.0% | -30.9% |
| 3Y3 Years | +924.6% | 0.0% | +645.2% |
| 5Y5 Years | +100.0% | - | - |
MLTX CAPEX Highs & Lows
| PeriodPeriod | Annual vs HighAnnual vs High | Annual vs LowAnnual vs Low | Quarter. vs HighQuarter. vs High | Quarter. vs LowQuarter. vs Low | TTM vs HighTTM vs High | TTM vs LowTTM vs Low | |
|---|---|---|---|---|---|---|---|
| 3Y | 3-Year | at high | +3146.9% | -100.0% | at low | -45.5% | >+9999.0% |
| 5Y | 5-Year | at high | >+9999.0% | -100.0% | at low | -45.5% | >+9999.0% |
| All-Time | All-Time | at high | >+9999.0% | -100.0% | at low | -45.5% | >+9999.0% |
MLTX CAPEX History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2025 | - | $0.00(-100.0%) | $342.80K(0.0%) |
| Mar 2025 | - | $35.00K(-80.1%) | $342.80K(-34.0%) |
| Dec 2024 | $519.50K(+82.5%) | $175.60K(+32.8%) | $519.60K(-17.3%) |
| Sep 2024 | - | $132.20K(>+9900.0%) | $628.60K(+26.6%) |
| Jun 2024 | - | $0.00(-100.0%) | $496.40K(0.0%) |
| Mar 2024 | - | $211.80K(-25.6%) | $496.40K(+74.4%) |
| Dec 2023 | $284.60K | $284.60K(>+9900.0%) | $284.60K(>+9900.0%) |
| Sep 2023 | - | $0.00(0.0%) | $0.00(0.0%) |
| Jun 2023 | - | $0.00(0.0%) | $0.00(0.0%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2023 | - | $0.00(0.0%) | $0.00(-100.0%) |
| Dec 2022 | $16.00K(-68.4%) | $0.00(0.0%) | $16.00K(-53.5%) |
| Sep 2022 | - | $0.00(0.0%) | $34.40K(-25.2%) |
| Jun 2022 | - | $0.00(-100.0%) | $46.00K(-31.0%) |
| Mar 2022 | - | $16.00K(-13.0%) | $66.70K(+31.6%) |
| Dec 2021 | $50.70K(>+9900.0%) | $18.40K(+58.6%) | $50.70K(+57.0%) |
| Sep 2021 | - | $11.60K(-44.0%) | $32.30K(+56.0%) |
| Jun 2021 | - | $20.70K(>+9900.0%) | $20.70K(>+9900.0%) |
| Mar 2021 | - | $0.00(0.0%) | $0.00(0.0%) |
| Dec 2020 | $0.00 | $0.00 | $0.00 |
FAQ
- What is MoonLake Immunotherapeutics annual capital expenditures?
- What is the all-time high annual CAPEX for MoonLake Immunotherapeutics?
- What is MoonLake Immunotherapeutics annual CAPEX year-on-year change?
- What is MoonLake Immunotherapeutics quarterly capital expenditures?
- What is the all-time high quarterly CAPEX for MoonLake Immunotherapeutics?
- What is MoonLake Immunotherapeutics quarterly CAPEX year-on-year change?
- What is MoonLake Immunotherapeutics TTM capital expenditures?
- What is the all-time high TTM CAPEX for MoonLake Immunotherapeutics?
- What is MoonLake Immunotherapeutics TTM CAPEX year-on-year change?
What is MoonLake Immunotherapeutics annual capital expenditures?
The current annual CAPEX of MLTX is $519.50K
What is the all-time high annual CAPEX for MoonLake Immunotherapeutics?
MoonLake Immunotherapeutics all-time high annual capital expenditures is $519.50K
What is MoonLake Immunotherapeutics annual CAPEX year-on-year change?
Over the past year, MLTX annual capital expenditures has changed by +$234.90K (+82.54%)
What is MoonLake Immunotherapeutics quarterly capital expenditures?
The current quarterly CAPEX of MLTX is $0.00
What is the all-time high quarterly CAPEX for MoonLake Immunotherapeutics?
MoonLake Immunotherapeutics all-time high quarterly capital expenditures is $284.60K
What is MoonLake Immunotherapeutics quarterly CAPEX year-on-year change?
Over the past year, MLTX quarterly capital expenditures has changed by $0.00 (0.00%)
What is MoonLake Immunotherapeutics TTM capital expenditures?
The current TTM CAPEX of MLTX is $342.80K
What is the all-time high TTM CAPEX for MoonLake Immunotherapeutics?
MoonLake Immunotherapeutics all-time high TTM capital expenditures is $628.60K
What is MoonLake Immunotherapeutics TTM CAPEX year-on-year change?
Over the past year, MLTX TTM capital expenditures has changed by -$153.60K (-30.94%)